uBriGene Biosciences is a world-class gene therapy CDMO supporting customers from concept to commercialization. Headquartered in Germantown, Maryland, uBriGene is dedicated to providing one-stop, viral vector–based CDMO services for research and clinical applications. The company operates five advanced GMP manufacturing sites worldwide — four in APAC and one in the U.S. — with 50 GMP production lines for plasmids, viral vectors, cell therapies, and RNA–LNP.